← All UK grants
OpenEuropean Commission (Horizon Europe)

Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications

Award
£6.9m to £8.6m
Closes
17 February 2027
Funder
European Commission (Horizon Europe)

Who can apply for Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications?

Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications is a funding programme from European Commission (Horizon Europe), offering £6.9m to £8.6m and closing on 17 February 2027. Below are the eligibility rules EchoGrant read from the funder's own page, grouped by what they cover. They are quoted from the funder, so treat the official page as the final word.

Who can apply

  • The participation of tart-up , micro, mall and medium- ized enterpri e (SME ) i encouraged with the aim of trengthening their cientific and technological foundation , enhancing their innovation potential, and exploring po ibilitie for commercial exploitation.

Where you need to be based

  • Location: UK. The UK i a ociated to Horizon Europe, o UK organi ation can apply on the ame term a EU one unle the condition below ay otherwi e.

Sector or focus

  • Thi topic aim at upporting activitie that are enabling or contributing to one or everal expected impact of de tination 'En uring equal acce to innovative, u tainable, and high-quality healthcare'.

What the funding is for

  • Leverage the role of pharmacogenomic , pharmacokinetic and pharmacodynamic in predicting and preventing adver e drug reaction in ituation of multiple medication (three or more drug admini tered concomitantly), and propo e per onali ed medicine approache , uch a targeted therapie and biomarker-driven treatment trategie .
  • Applicant hould provide detail of their clinical tudie in the dedicated annex u ing the template provided in the ubmi ion y tem. A propo al under thi topic are expected to include clinical tudie , the u e of the template i trongly encouraged.
  • Align with imilar work in other EU-funded project or partner hip , uch a the co-funded European Partner hip for Per onali ed Medicine, the co-funded European Partner hip on Tran forming Health and Care Sy tem etc. while avoiding any potential overlap .
  • The further u e of re ult generated by the project funded under thi topic hould be en ured through data haring with the relevant takeholder and the European Medicine Agency (EMA), in view of po ible adoption of depre cribing or adju ted-pre cribing guideline by relevant authoritie at EU and national level .

Do you meet these rules?

EchoGrant checks your organisation against every rule above and tells you which ones you pass, which you fail and which need an answer from you.

Common questions

Who can apply for Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications?

The participation of tart-up , micro, mall and medium- ized enterpri e (SME ) i encouraged with the aim of trengthening their cientific and technological foundation , enhancing their innovation potential, and exploring po ibilitie for commercial exploitation. This is the funder’s own wording; check the official page before you apply.

How much is the Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications award?

The funder’s page gives the award as £6.9m to £8.6m. Check the official page for how it is paid and any match funding.

When is the Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications deadline?

The deadline we have recorded is 17 February 2027. Funders sometimes move dates, so confirm on the official page.

Information is taken from the funder's public page and may be out of date. EchoGrant is not the funder and does not guarantee eligibility or funding. Always confirm details with the funder before applying.

Ready to Win Your Next Grant?

Try our free grant scoring tool to see your fit instantly, or book a strategy call to discuss how we can help you secure funding.

Free scoring • No signup required • Strategy calls are free